Guideline: Page 2

USPSTF: more evidence needed on diabetes screening
The Task Force concluded that more research is needed to recommend for or against screening children and adolescents without signs or symptoms.
September 12, 2022
2022 09 13 21 47 8940 Diabetes Woman Lancet 400
Week in Review: Roche’s new MDx system, HIV world market, cervical cancer testing disparities, and more
Dear LabPulse.com member,
August 24, 2022
Quest Diagnostics launches HCV obstetrics panel
The company developed the new test panel to include HCV antibody testing with a reflex to quantitative real-time PCR testing, in response to findings from a health trends study published in Obstetrics & Gynecology.
August 16, 2022
2020 04 02 20 02 8495 Quest Diagnostics 400
Bionano touts study on optical genome mapping
The results were published July 21 in the Journal of Neurology.
August 11, 2022
2022 04 18 13 42 3384 Dna Genome Gene Targeted 400
Foundation Medicine highlights lung cancer study results
The findings are from the Prospective Clinicogenomic (PCG) study and were published August 5 in the Journal of Thoracic Oncology Clinical and Research Reports.
August 7, 2022
2021 11 10 18 26 8156 Science Genome Sequence Dna Map 400
Guardant Health nabs coverage for liquid biopsy MRD test
The Guardant Reveal test detects circulating tumor DNA (ctDNA) in blood after surgery to help oncologists identify cancer patients with residual or recurring disease who may benefit most from adjuvant therapy.
August 1, 2022
2019 04 22 18 53 8505 Lab Blood Liquid Samples 400
AACC sees rise in impact of medical laboratory journal
The impact factor places it in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technology, AACC said.
July 20, 2022
2021 09 27 17 08 8174 Diagnostic Analyzer Lab Pcr 400
Veracyte genomic test classifies lung cancer risk in study
In a study published in the journal PLOS One, a group of researchers has clinically confirmed that Veracyte's Percepta Genomic Sequencing Classifier (GSC) can accurately classify lung cancer risk from inconclusive samples taken in a bronchoscopy.
July 19, 2022
2022 04 18 13 42 3384 Dna Genome Gene Targeted 400
Mercy Research to offer Grail multicancer blood test
The test, which aims to complement U.S. guideline-recommended cancer screenings, looks for a shared signal present in the bloodstream that has been associated with many cancers.
July 12, 2022
2021 04 19 16 59 1236 Fingerprick Blood 400
Exact Sciences supports CMS screening policy changes
The CMS Calendar Year 2023 Physician Fee Schedule proposal considers follow-up colonoscopy to an at-home test as a preventative service. The rule would eliminate all costs to Medicare patients for a follow-up colonoscopy following a positive at-home colorectal cancer screening test.
July 10, 2022
2019 09 23 17 18 0797 Colon Intestine 400
Fountain Health Insurance to cover Grail multicancer test
In a clinical study, the Galleri test demonstrated that it detects a shared signal from more than 50 types of cancers. More than 45 of them currently lack recommended screening tests, the firms noted.
June 21, 2022
2021 06 07 23 26 6198 Blood Tube Tumor Marker Test 400
Study: less than half of pregnant people screened for HCV
Quest noted that the CDC and the U.S. Preventive Services Task Force (USPSTF) published guidelines in early 2020 acknowledging the value of HCV antibody screening in response to growing rates of infection. A significant increase in screening was seen following the guidelines but many patients are still not receiving the recommended testing, Quest noted.
June 12, 2022
2020 03 03 23 13 0226 Hepatitis C Virus 400
Previous Page
Page 2 of 8
Next Page